The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
The Treatment of Hypertension in Adult Patients With Diabetes
Open accessAbstract
Hypertension is an extremely common comorbidity of diabetes, affecting 20–60% of people with diabetes. Hypertension is also a major risk factor for cardiovascular events, such as myocardial infarction and stroke, as well as for microvascular complications, such as retinopathy and nephropathy. Cardiovascular disease is the most costly complication of diabetes and is the cause of 86% of deaths in persons with diabetes (1). However, until recently, little research had been done specifically in patients with diabetes and hypertension. In reviewing the literature on diabetes and hypertension, the authors searched MEDLINE for English language articles using keywords “hypertension,” “diabetes mellitus,” “diabetic nephropathy,” and “coronary artery disease/prevention” starting from 1966. Before 1996, most available data come from secondary analysis from studies done in the general population of people with hypertension, observing a subset with diabetes. Recent studies have demonstrated the effectiveness of blood pressure treatment versus placebo in reducing complications of diabetes (2,3), helped to define the optimal level of blood pressure control (4,5,6), and compared treatment strategies based on different drug classes (7,8,9,10,11,12,13). The results of these studies support an aggressive approach to the diagnosis and treatment of hypertension in patients with diabetes in order to substantially reduce the incidence of both macrovascular and microvascular complications. ### Definition of hypertension in diabetic populations Epidemiological studies and therapeutic trials have often used different criteria to define hypertension in diabetic patients. Studies in the general population indicate an increased risk of cardiovascular disease with an increase in the level of blood pressure. Thus, an increase in diastolic or systolic blood pressure of 5 mmHg is associated with a concomitant increase in cardiovascular disease of 20–30% (14). Studies in diabetic populations have shown a markedly higher frequency of the progression of diabetic retinopathy …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“weight loss of 1 kilogram has been reported to decrease mean arterial blood pressure by approximately 1 mm Hg.”
From The case for low carbohydrate diets in diabetes management (2005) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
MACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253 · cited 1×
“Thus, an increase in diastolic or systolic blood pressure of 5 mmHg is associated with a concomitant increase in cardiovascular disease of 20–30% (14).”
Background(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,527
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
(2000) · PubMed · Cited by 2,095
Hansson, L., Lindholm, L. H., NISKANEN, L. K., Lanke, J., Hedner, T., Niklason, A., LUOMANMÄKI, K., Dahlöf, B., Fairé, U. D., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 1,991
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B., et al. (1998) · BMJ · doi:10.1136/bmj.317.7160.713 · Cited by 1,789
Hansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & Fairé, U. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,442
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406
Preserving renal function in adults with hypertension and diabetes: A consensus approach
Bakris, G. L., Williams, M. E., Dworkin, L. D., Elliott, W. J., Epstein, M., Toto, R. D., Tuttle, K. R., Douglas, J. G., Hsueh, W. A., & Sowers, J. R. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16225 · Cited by 1,396
Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T., & Ruilope, L. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02527-7 · Cited by 1,206
Furberg, C. D., Psaty, B. M., & Meyer, J. V. (1995) · Circulation · doi:10.1161/01.cir.92.5.1326 · Cited by 1,169
Estacio, R. O., Jeffers, B. W., Hiatt, W. R., Biggerstaff, S. L., Gifford, N., & Schrier, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381003 · Cited by 1,151
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
DeFronzo, R. A., Cooke, C. R., Andres, R., Faloona, G. R., & Davis, P. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107996 · Cited by 1,104
Mogensen, C. E., Neldam, S., Tikkanen, I., Oren, S., Viskoper, R. J., Watts, R. W., & Cooper, M. E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1440 · Cited by 1,026
Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
Tuomilehto, J. O., Rastenytė, D., Birkenhäger, W. H., Thijs, L., Antikaínen, R., Bulpitt, C. J., FLETCHER, A. E., Forette, F., Goldhaber, A., Palatini, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400902 · Cited by 932
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Hansson, L., Hedner, T., Lund‐Johansen, P., Kjeldsen, S. E., Lindholm, L. H., Syvertsen, J. O., Lanke, J., Fairé, U. D., Dahlöf, B., & Karlberg, B. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02526-5 · Cited by 903
Tatti, P., Pahor, M., Byington, R. P., Mauro, P. D., Guarisco, R., Strollo, G., & Strollo, F. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.597 · Cited by 843
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
Mogensen, C. E. (1982) · BMJ · doi:10.1136/bmj.285.6343.685 · Cited by 756
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
Kernan, W. N., Viscoli, C. M., Brass, L. M., Broderick, J. P., Brott, T. G., Feldmann, E. G., Morgenstern, L. B., Wilterdink, J. L., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432501 · Cited by 746
(2000) · PubMed · Cited by 691
Effect of Reduced Dietary Sodium on Blood Pressure
Midgley, J. (1996) · JAMA · doi:10.1001/jama.1996.03530440070039 · Cited by 595
Davis, B. R. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00037-4 · Cited by 594
Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
Parving, H., Andersen, A. R., Smidt, U. M., Hommel, E. E., Mathiesen, E. R., & Svendsen, P. A. (1987) · BMJ · doi:10.1136/bmj.294.6585.1443 · Cited by 534
Randomized trials of sodium reduction: an overview
Cutler, J., Follmann, D. A., & Allender, P. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.643s · Cited by 523
&NA;, &. (1993) · Journal of Hypertension · doi:10.1097/00004872-199303000-00012 · Cited by 491
Nelson, R. G., Bennett, P. H., Beck, G. J., Tan, M., Knowler, W. C., Mitch, W. E., Hirschman, G. H., & Myers, B. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352203 · Cited by 471
Mathiesen, E. R., Hommel, E. E., Giese, J., & Parving, H. ‐. (1991) · BMJ · doi:10.1136/bmj.303.6794.81 · Cited by 465
Bakris, G. L., Copley, J. B., Vicknair, N., Sadler, R., & Leurgans, S. (1996) · Kidney International · doi:10.1038/ki.1996.480 · Cited by 417
Haire-Joshu, D., Glasgow, R. E., & Tibbs, T. L. (1999) · Diabetes Care · doi:10.2337/diacare.22.11.1887 · Cited by 381
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
Marre, M., Châtellier, G., Leblanc, H., Guyene, T. T., Ménard, J., & Passa, P. (1988) · BMJ · doi:10.1136/bmj.297.6656.1092 · Cited by 372
Pollare, T., Lithell, H., Selinus, I., & Berne, C. (1988) · Diabetologia · doi:10.1007/bf00271585 · Cited by 354
The ACE Inhibitors in Diabetic Nephropathy Trialist Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-5-200103060-00009 · Cited by 338
Parving, H. ‐., Hommel, E. E., & Smidt, U. (1988) · BMJ · doi:10.1136/bmj.297.6656.1086 · Cited by 330
Pharmacology of Antihypertensive Drugs.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-650_9 · Cited by 325
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · Cited by 302
UK Prospective Diabetes Study Group (1998) · BMJ · doi:10.1136/bmj.317.7160.720 · Cited by 301
Chaturvedi, N. (2001) · UCL Discovery (University College London) · Cited by 299
Andersen, S., Tarnow, L., Rossing, P. R., Hansen, B. V., & Parving, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00880.x · Cited by 287
Standards of Medical Care for Patients With Diabetes Mellitus
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s33 · Cited by 264
Relationship Between Blood Pressure and Urinary Albumin Excretion in Development of Microalbuminuria
Mathiesen, E. R., Rønn, B. B., Jensen, T. J., Storm, B., & Deckert, T. (1990) · Diabetes · doi:10.2337/diab.39.2.245 · Cited by 251
Efficacy and Safety of Sibutramine in Obese White and African American Patients With Hypertension
McMahon, F. G., Fujioka, K., Singh, B. N., Mendel, C. M., Rowe, E., Rolston, K., Johnson, F. K., & Mooradian, A. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2185 · Cited by 246
Prevalence of Diabetic Complications in Relation to Risk Factors
Knuiman, M. W., Welborn, T. A., McCann, V. J., Stanton, K. G., & Constable, I. J. (1986) · Diabetes · doi:10.2337/diab.35.12.1332 · Cited by 242
Lacourcière, Y., Bélanger, A., Godin, C., Hallé, J., Ross, S. A., Wright, N., & Marion, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00224.x · Cited by 226
The Progressive Cost of Complications in Type 2 Diabetes Mellitus
Brown, J. B., Pedula, K. L., & Bakst, A. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1873 · Cited by 216
Feldt‐Rasmussen, B., Mathiesen, E. R., Deckert, T., Giese, J., Christensen, N. J., Bent-Hansen, L., & Nielsen, M. D. (1987) · Diabetologia · doi:10.1007/bf00277316 · Cited by 202
Relation of Ocular and Systemic Factors to Survival in Diabetes
Klein, R. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390020016004 · Cited by 200
Geleijnse, J. M., Witteman, J. C. M., Bak, A. A. A., den Breeijen, J. H., & Grobbee, D. E. (1994) · BMJ · doi:10.1136/bmj.309.6952.436 · Cited by 185
Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus
de Châtel, R., Weidmann, P., Flammer, J., Ziegler, W. H., Beretta-Piccoli, C., Vetter, W., & Reubi, F. C. (1977) · Kidney International · doi:10.1038/ki.1977.132 · Cited by 182
Nielsen, F. S., Rossing, P. R., Gall, M.-A., Skøtt, P., Smidt, U., & Parving, H. (1997) · Diabetes · doi:10.2337/diab.46.7.1182 · Cited by 182
Heal, D. J., Aspley, S., Prow, M. R., Jackson, H. C., Martin, K. F., & Cheetham, S. (1998) · PubMed · Cited by 178
Mortality Trends in Type 1 Diabetes
Nishimura, R., LaPorte, R. E., Dorman, J. S., Tajima, N., BECKER, D. J., & Orchard, T. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.823 · Cited by 170
Schillaci, G., & Vaudo, G. (2001) · PubMed · Cited by 167
Effects of Diltiazem or Lisinopril on Massive Proteinuria Associated with Diabetes Mellitus
Bakris, G. L. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-707 · Cited by 166
Effects of Cilazapril and Amlodipine on Kidney Function in Hypertensive NIDDM Patients
Velussi, M., Brocco, E., Frigato, F., Zolli, M., Muollo, B., Maioli, M., Carraro, A., Tonolo, G., Fresu, P., Cernigoi, A. M., et al. (1996) · Diabetes · doi:10.2337/diab.45.2.216 · Cited by 157
Bakris, G. L., Mangrum, A. J., Copley, J. B., Vicknair, N., & Sadler, R. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.744 · Cited by 147
Excess Mortality Associated With Diuretic Therapy in Diabetes Mellitus
Warram, J. H. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400070114014 · Cited by 145
Risk Factors for Progression of Background Retinopathy in Long-Standing IDDM
Janka, H. U., Warram, J. H., Rand, L. I., & Królewski, A. S. (1989) · Diabetes · doi:10.2337/diab.38.4.460 · Cited by 144
Hasslacher, C., Stech, W., Wahl, P. M., & Ritz, E. (1985) · Diabetologia · doi:10.1007/bf00276992 · Cited by 143
Losartan and Low-Dose Hydrochlorothiazide in Patients With Essential Hypertension
MacKay, J. H. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440030072009 · Cited by 142
Diabetic Autonomic Neuropathy and Cardiovascular Risk
Maser, R. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.6.1218 · Cited by 136
Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials
Midgley, J. (1996) · JAMA · doi:10.1001/jama.275.20.1590 · Cited by 134
The Effects of Weight Reduction on Blood Pressure in 301 Obese Patients
Schotte, D. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00040031701019 · Cited by 129
Newer Approaches to Antihypertensive Therapy
Epstein, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440160081011 · Cited by 129
Hyperkalemia as a Complication of Drug Therapy
Rimmer, J. M. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370050063011 · Cited by 128
Pharmacokinetic profile of ceftriaxone in man.
Patel, I. H., & Kaplan, S. A. (1984) · PubMed · Cited by 128
Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy.
O’Hare, J. A., Ferriss, J. B., Brady, D., Twomey, B. M., & O’Sullivan, D. J. (1985) · Hypertension · doi:10.1161/01.hyp.7.6_pt_2.ii43 · Cited by 124
Treatment of Hypertension: Drug Therapy
Lee, B. H. (1997) · Korean Circulation Journal · doi:10.4070/kcj.1997.27.3.350 · Cited by 98
Aspects of Tolerability of Centrally Acting Antihypertensive Drugs
Webster, J., & Koch, H. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199627003-00007 · Cited by 87
Cellular ions in hypertension, insulin resistance, obesity, and diabetes
Resnick, L. M. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v34s78 · Cited by 86
Harper, R., Ennis, C. N., Heaney, A., Sheridan, B., Gormley, M., Atkinson, A. B., Johnston, G., & Bell, P. M. (1995) · Diabetologia · doi:10.1007/s001250050363 · Cited by 84
Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria
Mathiesen, E. R., Rønn, B. B., Jensen, T., et al. (1990) · Diabetes · doi:10.2337/diabetes.39.2.245 · Cited by 82
Lender, D. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00259-3 · Cited by 79
Prevalence of diabetic complications in relation to risk factors
Knuiman, M. W., Welborn, T. A., Vj, M., et al. (1986) · Diabetes · doi:10.2337/diabetes.35.12.1332 · Cited by 79
Body weight, sodium intake and blood pressure
Staessen, J. A., Fagard, R. H., Lijnen, P. J., & Amery, A. K. P. C. (1989) · Journal of Hypertension · doi:10.1097/00004872-198902001-00006 · Cited by 76
Cost-effectiveness of the Lower Treatment Goal (of JNC VI) for Diabetic Hypertensive Patients
Elliott, W. J., Weir, D. R., & Black, H. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1277 · Cited by 73
Ruilope, L. M., Simpson, R. L., Toh, J., Arcuri, K. E., Goldberg, A. I., & Sweet, C. S. (1996) · Blood Pressure · doi:10.3109/08037059609062104 · Cited by 73
Implications of discontinuation of doxazosin arm of ALLHAT
Messerli, F. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)00092-1 · Cited by 69
Johannesson, M., Dahlöf, B., Lindholm, L. H., Ekbom, T., Hansson, L., Odén, A., Scherstén, B., Wester, P. O., & Jönsson, B. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00749.x · Cited by 69
Epidemiologic Review of the Calcium Channel Blocker Drugs
Kizer, J. R., & Kimmel, S. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1145 · Cited by 65
Prince, M. J. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.11.2363 · Cited by 61
Rossing, P. R., Tarnow, L., Boelskifte, S., Jensen, B. R., Nielsen, F. S., & Parving, H. (1997) · Diabetes · doi:10.2337/diab.46.3.481 · Cited by 59
Essential Hypertension Is Associated With Decreased Insulin Clearance and Insulin Resistance
Lender, D., Arauz-Pacheco, C., ADAMS-HUET, B. A., & Raskin, P. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.111 · Cited by 55
Self-citationBeta-blockers in hypertensive and coronary heart disease
Goldstein, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.12.1267 · Cited by 55
Schneider, M., Lerch, M., Papiri, M., Buechel, P., Böhlen, L., Shaw, S., Risen, W., & Wiedmann, P. (1996) · Journal of Hypertension · doi:10.1097/00004872-199605000-00018 · Cited by 51
Risk factors for progression of background retinopathy in long-standing IDDM
Janka, H. U., Warram, J. H., Rand, L. I., et al. (1989) · Diabetes · doi:10.2337/diabetes.38.4.460 · Cited by 47
Metabolic disturbances in hypertension: results from the population study ‘ Men born in 1913’
Eriksson, H., Welin, L., Wilhelmsen, L., Larsson, B., Ohlson, L. ‐., Svärdsudd, K., & Tibblin, G. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00604.x · Cited by 45
Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients
Velussi, M., Brocco, E., Frigato, F., et al. (1996) · Diabetes · doi:10.2337/diabetes.45.2.216 · Cited by 45
Relation of ocular and systemic factors to survival in diabetes
Klein, R. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.2.266 · Cited by 44
Role of Alpha Adrenoceptors in Hypertension and in Anti hypertensive Drug Treatment
van Zwieten, P. A., Timmermans, P. B. M. W. M., & van Brummelen, P. (1984) · The American Journal of Medicine · doi:10.1016/s0002-9343(84)80033-9 · Cited by 40
Sowers, J. R. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00751-6 · Cited by 40
Triggle, D. J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00732-1 · Cited by 38
Johannesson, M., Agewall, S., Hartford, M., Hedner, T., & Fagerberg, B. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01135.x · Cited by 32
CLAUSEN‐SJÖBOM, N., LINS, P.-E. S., Adamson, U., Curstedt, T., & Hamberger, B. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb09929.x · Cited by 31
Hermans, M. P., Brichard, S. M., Colin, I. M., Borgies, P., Ketelslegers, J., & Lambert, A. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90158-8 · Cited by 29
Lant, A. F. (1986) · Drugs · doi:10.2165/00003495-198600314-00006 · Cited by 29
Jh, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.3.278 · Cited by 28
Effects of Atenolol and Enalapril on Kidney Function in Hypertensive Diabetic Patients
Cesaris, R. D., Ranieri, G., Filitti, V., Andriani, A., & Bonfantino, M. V. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199308000-00006 · Cited by 27
Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy
Epstein, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.17.1969 · Cited by 26
Pahor, M., Psaty, B. M., & Furberg, C. D. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199800004-00004 · Cited by 23
The effects of weight reduction on blood pressure in 301 obese patients
Schotte, D. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.8.1701 · Cited by 23
Excess mortality associated with diuretic therapy in diabetes mellitus
Warram, J. H. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.7.1350 · Cited by 23
Labia, R., Barthélémy, M., Bouguénec, C. L., & Buu-Hoï, A. (1986) · Drugs · doi:10.2165/00003495-198600313-00011 · Cited by 22
Calcium antagonists and cardiovascular risk in diabetes
Parving, H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00758-9 · Cited by 21
Calcium intake and blood pressure: epidemiology revisited.
Cd, M., & Me, R. (1995) · PubMed · Cited by 16
Calcium antagonists and the diabetic patient: a response to recent controversies
Poulter, N. R. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00757-7 · Cited by 15
Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
Piñol, C., Cobos, A., Cases, A., Esmatges, E., Soler, J., Closas, J., Pascual, R., & Planas, J. (1996) · PubMed · Cited by 15
Ferrari, R., Ceconi, C., Curello, S., Pepi, P., Mazzoletti, A., & Visioli, O. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00052511 · Cited by 14
Rossing, P., Tarnow, L., Boelskifte, S., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.3.481 · Cited by 14
Messerli, F. H., & Grossman, E. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00756-5 · Cited by 12
Hyperkalemia as a complication of drug therapy
Rimmer, J. M. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.5.867 · Cited by 12
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s80 · Cited by 11
Dietary Factors and Blood Pressure Regulation
Moore, T. J., & McKnight, J. A. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30036-7 · Cited by 9
Kwan, C. M., Shepherd, A. M. M., Johnson, J. M., Taylor, W. F., & Brockway, B. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90131-9 · Cited by 8
CHLORTHALIDONE-MODULATED VASCULAR RESPONSES TO VASODILATOR STIMULI IN DOCA-SALT HYPERTENSIVE RATS
Bissoli, N. S. (1996) · Pharmacological Research · doi:10.1006/phrs.1996.0008 · Cited by 7
Elving, L. D., de Nobel, E., van Lier, H. J. J., & Thien, T. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03334.x · Cited by 7
Mason, R. P., & Mason, P. E. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00754-1 · Cited by 6
Krzesinski, J. M., Janssens, M., Vanderspeeten, F., & Rorive, G. L. (1993) · Acta Clinica Belgica · doi:10.1080/17843286.1993.11718314 · Cited by 5
Cited by
Sorted by citations
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
“Evidence is summarized in the following sections and reviewed in detail in the ADA technical reviews on hypertension (155), dyslipidemia (156), aspirin therapy (157), and smoking cessation (158) and in the American Heart Association (AHA)/ADA scientific statement on prevention of CVD in people with diabetes (159).”
Standards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,885
“Evidence is summarized in the following sections and reviewed in detail in the ADA technical reviews on hypertension (100), dyslipidemia (101), aspirin therapy (102), and smoking cessation (103) and the consensus statement on CHD in people with diabetes (104).”
Standards of Medical Care in Diabetes 2014
(2014) · Majmaah Journal of Health Sciences · doi:10.12816/0004790 · Cited by 1,478
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
“Evidence is summarized in the following sections and reviewed in detail in the ADA technical reviews on hypertension (125), dyslipidemia (126), aspirin therapy (127), and smoking cessation (128), and in the AHA/ ADA scientific statement on prevention of CVD in people with diabetes (129).”
Nowy rok, stare problemy, ale i nowe możliwości
Czupryniak, L. (2014) · Via Medica Journals · Cited by 1,192
Metadata
- Authors
- Arauz-Pacheco, C., Parrott, M. A., & Raskin, P.
- Affiliations
- George Washington University (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2002-01-01
- Volume
- 25
- Issue
- 1
- Pages
- 134-147
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2138299277
- Cited by
- 326
- References
- 129
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 11 · 2019: 8 · 2018: 4 · 2017: 14 · 2016: 14 · 2015: 15 · 2014: 16 · 2013: 12 · 2012: 19
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hypertension, diabetes mellitus, antihypertensive therapy, blood pressure control, diabetic nephropathy, diabetic retinopathy, cardiovascular complications, microvascular complications, antihypertensive drug classes
- MeSH terms
- Adult, Diabetic Angiopathies, Female, Humans, Hypertension, Lactation, Pregnancy, Pregnancy in Diabetics, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review